表紙
市場調查報告書
商品編碼
1082787

流鼻血設備的全球市場(2022年∼2029年)

Global Epistaxis Device Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球流鼻血設備調查分析,市場概要,以及市場趨勢,推動及阻礙市場要素,COVID-19影響,產業分析,各市場區隔、各地區的市場分析,競爭情形,企業簡介等資訊。

目錄

第1章 全球流鼻血設備市場:範圍調查手法

  • 調查手法
  • 調查的目的和調查範圍

第2章 全球流鼻血設備市場:市場定義和概要

第3章 全球流鼻血設備市場:摘要整理

  • 各類型的市場明細
  • 各用途的市場明細
  • 各地區的市場明細

第4章 全球流鼻血設備市場動態

  • 影響市場的要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響分析

第5章 全球流鼻血設備市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析
  • 未滿足需求

第6章 全球流鼻血設備市場:COVID-19分析

  • 市場的COVID-19影響分析
    • COVID-19前的市場情境
    • COVID-19目前市場情境
    • COVID-19後或未來情境
  • COVID-19的價格變動
  • 需求與供給的頻譜
  • 大流行時的市場相關的政府的配合措施
  • 製造商策略性配合措施
  • 結論

第7章 全球流鼻血設備市場:各產品類型

  • 簡介
  • 市場規模分析、與前一年同期比較成長分析(%):各產品類型
  • 市場魅力指數:各產品類型
    • 經鼻導管
    • 鼻子棉塞
    • 其他

第8章 全球流鼻血設備市場:各用途

  • 簡介
    • 市場規模分析、與前一年同期比較成長分析(%):各用途
    • 市場魅力指數:各用途
  • 前部流鼻血
    • 簡介
    • 市場規模分析、與前一年同期比較成長分析(%):2020年∼2029年,及2021年∼2029年(百萬美元)
  • 後部流鼻血

第9章 全球流鼻血設備市場:各地區

  • 簡介
    • 各地區的市場規模分析、與前一年同期比較成長分析(%):2020年∼2029年,及2021年∼2029年(百萬美元)
    • 市場魅力指數:各地區
  • 北美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析、與前一年同期比較成長分析(%):各產品類型
    • 市場規模分析、與前一年同期比較成長分析(%):各用途
    • 市場規模分析、與前一年同期比較成長分析(%):各國
  • 歐洲
    • 簡介
    • 主要地區具體動態
    • 市場規模分析、與前一年同期比較成長分析(%):各產品類型
    • 市場規模分析、與前一年同期比較成長分析(%):各用途
    • 市場規模分析、與前一年同期比較成長分析(%):各國
  • 南美
    • 簡介
    • 主要地區具體動態
    • 市場規模分析、與前一年同期比較成長分析(%):各產品類型
    • 市場規模分析、與前一年同期比較成長分析(%):各用途
    • 市場規模分析、與前一年同期比較成長分析(%):各國
  • 亞太地區
    • 簡介
    • 主要地區具體動態
    • 市場規模分析、與前一年同期比較成長分析(%):各產品類型
    • 市場規模分析、與前一年同期比較成長分析(%):各用途
    • 市場規模分析、與前一年同期比較成長分析(%):各國
  • 中東和非洲
    • 簡介
    • 主要地區具體動態
    • 市場規模分析、與前一年同期比較成長分析(%):各產品類型
    • 市場規模分析、與前一年同期比較成長分析(%):各用途

第10章 全球流鼻血設備市場:競爭情形

  • 主要的開發與策略
  • 企業佔有率分析
  • 產品的基準

第11章 全球流鼻血設備市場:企業簡介

  • Smith & Nephew
    • 企業概要
    • 產品系列、說明
    • 主要亮點
    • 財務概要
  • Stryker Corp
  • Teleflex Incorporated
  • SPIGGLE & THEIS Medizintechnik GmbH
  • Summit Medical LLC.
  • EON Meditech

第12章 全球流鼻血設備市場:DataM

目錄
Product Code: DMMD5240

Market Overview

The global epistaxis device market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Epistaxis, or nose bleeding, is a common occurrence. It is rarely life-threatening. This clinical condition is classified as posterior epistaxis or anterior epistaxis, depending on where the bleeding starts.

Market Dynamics

The factors influencing the global epistaxis device market are the increasing demand for the treatment of epistaxis and the growing prevalence of epistaxis.

The increasing demand for the treatment of epistaxis is expected to drive the market growth

Epistaxis can come from either an anterior or posterior source, but it usually starts in the anterior nasal cavity. A detailed history and physical examination usually determine the cause of the bleeding. Both local and systemic processes can cause epistaxis. Nasal bleeding is usually treated with compression and other first-aid measures. When simple measures fail to relieve epistaxis, the source of the bleeding should be identified and treated appropriately. Topical vasoconstriction, chemical cautery, electrocautery, nasal packing (nasal tampon or gauze impregnated with petroleum jelly), posterior gauze packing, balloon therapy (including a modified Foley catheter), and arterial ligation or embolization are all options to consider. Antibiotics, either topical or systemic, should be used in certain patients. Moreover, RAPHID RHINO technology, a proprietary blend of CarboxyMethyl Cellulose, is used in Epistaxis products (CMC). This CMC-infused fabric has self-lubricating properties that turn into a gel consistency when wet, making it easier to insert and remove. The epistaxis solutions' ultra-low profile conforms quickly to anatomy and provides gentle, even compression to the nasal area.

Limitations associated with epistaxis device is expected to hamper the market growth

Patients with anterior nosebleeds can be discharged after the bleeding has been controlled and hemodynamic stability observed for at least one hour in the emergency department (ED). All predisposing factors have been medically optimized. In one week, they should see an otolaryngologist or their primary care physician, and they should start using nasal saline three times per day. If non-biodegradable packing is used, patients should return to the ED or ENT in three to five days for packing removal. If a patient requires posterior packing, including pediatric patients, admission is required to monitor for complications, particularly cardiac arrhythmias. If discontinuation is not possible, all anticoagulants should be reversed or withheld to achieve the lowest dose acceptable. If appropriate equipment and follow-up are available, an anterior bleed can often be safely managed in primary care. If direct pressure fails to stop the bleeding, cautery or nasal packing are options. Silver nitrate is impregnated in cautery sticks, causing a chemical burn when it reacts with the mucosal lining. To avoid septal perforation, care must be taken during bilateral cautery, and treatment should be limited to a small area surrounding the bleeding point. After cauterization, patients should be put on a nasal moisturizer like Kenacomb or paraffin.

COVID-19 Impact Analysis

Due to the highly virulent nature of COVID-19 in respiratory droplets and nasal secretions, otolaryngologists are concerned about epistaxis management in COVID-19-positive patients. Another point of concern is the lack of mention of diagnostic nasal endoscopy. Nasal endoscopy aids in diagnosing a variety of mass lesions and provides a clear view of the nasal cavity and nasopharynx. It's also a procedure that's considered minimally invasive. As a result, it is recommended in cases where bleeding has stopped despite non-invasive measures. Another thing to think about is the role of posterior nasal packing in recommended cases and how important it is in the COVID-19 era. Hence, covid-19 has negatively affected the global epistaxis device market.

Segment Analysis

Nasal Catheters segment is expected to dominate the market growth

EPISTAXIS is a common clinical condition that has a variety of treatment options. The most common and traditional treatment for the posterior type of epistaxis is placing an inflated Foley catheter balloon in the nasopharynx and an anterior gauze pack. A typical description includes a 10 to 15 mL balloon inflation volume and the application of traction, which is maintained by sliding the catheter over a piece of plastic tubing and clamping the two tubes together.

The inflated Foley catheter balloon, for instance, may act as a stable platform in the nasopharynx for the insertion of an anterior gauze packing, which is solely responsible for stopping the epistaxis. In another mode of action, the balloon may compress the bleeding vessels and prevent bleeding down the oropharynx when effective traction is applied to the catheter. Although these and other theories offer plausible explanations for the Foley balloon's action in treating posterior epistaxis, none have been thoroughly investigated or described.

Geographical Analysis

North America region is expected to hold the largest market share in the global epistaxis device market

The growing prevalence of epistaxis and increasing research and development in this region is expected to drive the market growth.

A blood vessel inside the nose bursts, causing nosebleeds. Epistaxis is the medical term for nosebleeds. In the United States, up to 60 million people suffer from nosebleeds. They are most common in the winter when the cold weather and indoor heating exacerbate the dryness of the nasal passages.

Competitive Landscape

The global epistaxis device market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Smith & Nephew, Stryker Corp., Teleflex Incorporated, SPIGGLE & THEIS Medizintechnik GmbH, Summit Medical LLC., EON Meditech

Smith & Nephew

  • Overview: Smith & Nephew plc, or Smith+Nephew, is a British multinational medical equipment manufacturer based in Watford, England. The company was founded in 1856.
  • Product Portfolio: High volume, low-pressure tamponade is used in Rapid Rhino devices to ensure gentle, even compression and control epistaxis at the source of the bleed. Rapid Rhino has a unique design that prevents epistaxis from occurring in the first place and is more comfortable for patients to insert and remove than other packing options.

Why Purchase the Report?

  • Visualize the composition of the global epistaxis device market segmentation By Product Type and distribution channel highlighting the key commercial assets and players.
  • Identify commercial opportunities in global epistaxis device market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global epistaxis device market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global epistaxis device market report would provide an access to an approx. 45+ market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Epistaxis Device Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Epistaxis Device Market- Market Definition and Overview

3. Epistaxis Device Market- Executive Summary

  • 3.1. Market Snippet By Product Type
  • 3.2. Market Snippet By Application
  • 3.3. Market Snippet By Region

4. Epistaxis Device Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. The increasing demand for the treatment of epistaxis
    • 4.1.2. Restraints:
      • 4.1.2.1. Limitations associated with epistaxis device
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Epistaxis Device Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs

6. Epistaxis Device Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Epistaxis Device Market-By Product Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.3. Market Attractiveness Index, By Product Type
    • 7.3.1. Nasal Catheters*
      • 7.3.1.1.1. Introduction
      • 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.3.2. Nasal Tampons
    • 7.3.3. Others

8. Epistaxis Device Market- By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Anterior epistaxis
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Posterior epistaxis

9. Epistaxis Device Market- By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Epistaxis Device Market- Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking

11. Epistaxis Device Market- Company Profiles

  • 11.1. Smith & Nephew*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Stryker Corp
  • 11.3. Teleflex Incorporated
  • 11.4. SPIGGLE & THEIS Medizintechnik GmbH
  • 11.5. Summit Medical LLC.
  • 11.6. EON Meditech

LIST NOT EXHAUSTIVE

12. Epistaxis Device Market- DataM

    • 12.1.1. Appendix
    • 12.1.2. About Us and Services
    • 12.1.3. Contact Us